Overview

A Study to Investigate the Effects of BMS-986278 on Drospirenone and Ethinyl Estradiol Drug Levels in Healthy Female Participants

Status:
Completed

Trial end date:
2023-12-11

Target enrollment:

Participant gender:

Summary

The purpose of the study is to assess the effects of BMS-986278 on Drospirenone (DRSP) and Ethinyl Estradiol (EE) when administered as a combined oral contraceptive in healthy female participants.

Phase:

Phase 1

Details

Lead Sponsor:

Bristol-Myers Squibb

Treatments:

Drospirenone
Drospirenone and ethinyl estradiol combination
Estradiol
Ethinyl Estradiol